Industry: Medical Devices & Consumables
Published Date: 2026-01-04
Pages: 138 Pages
Report ld: 5528352
Request Sample
Customized Report
Hemostatic Forceps Market Size(US$)

CAGR 2026-2032
4.3%
Market Size,2032
USD 90.6
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Hemostatic Forceps market was valued at US$ 67.75 million in 2025 and is anticipated to reach US$ 90.6 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hemostatic Forceps competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.
Global Hemostatic Forceps key players include Medline, B. Braun, CareFusion, Sklar, Scanlan International, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 30%, followed by Europe and China, both have a share about 45%.
In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.
This report delivers a comprehensive overview of the global Hemostatic Forceps market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hemostatic Forceps. The Hemostatic Forceps market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hemostatic Forceps market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hemostatic Forceps manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Hemostatic Forceps manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Hemostatic Forceps sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Hemostatic Forceps Market Overview
1.1 Product Definition
1.2 Hemostatic Forceps by Type
1.2.1 Global Hemostatic Forceps Market Value by Type: 2025 vs 2032
1.2.2 Halstead Mosquito Hemostatic Forceps
1.2.3 Kelly and Crile Hemostatic Forceps
1.2.4 Rochester-Carmalt Hemostatic Forceps
1.3 Hemostatic Forceps by Application
1.3.1 Global Hemostatic Forceps Market Value by Application: 2025 vs 2032
1.3.2 Surgical
1.3.3 Dissection
1.3.4 Dental
1.3.5 Laparoscopic
1.3.6 Others
1.4 Global Hemostatic Forceps Market Size Estimates and Forecasts
1.4.1 Global Hemostatic Forceps Revenue 2021–2032
1.4.2 Global Hemostatic Forceps Sales 2021–2032
1.4.3 Global Hemostatic Forceps Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Hemostatic Forceps Market Competition by Manufacturers
2.1 Global Hemostatic Forceps Sales Market Share by Manufacturers (2021–2026)
2.2 Global Hemostatic Forceps Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Hemostatic Forceps Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Hemostatic Forceps, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Hemostatic Forceps, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Hemostatic Forceps, Product Types and Applications
2.7 Global Key Manufacturers of Hemostatic Forceps, Date of Entry into the Industry
2.8 Global Hemostatic Forceps Market Competitive Situation and Trends
2.8.1 Global Hemostatic Forceps Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Hemostatic Forceps Players Market Share by Revenue
2.8.3 Global Hemostatic Forceps Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemostatic Forceps Market Scenario by Region
3.1 Global Hemostatic Forceps Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Hemostatic Forceps Sales by Region: 2021–2032
3.2.1 Global Hemostatic Forceps Sales by Region: 2021–2026
3.2.2 Global Hemostatic Forceps Sales by Region: 2027–2032
3.3 Global Hemostatic Forceps Revenue by Region: 2021–2032
3.3.1 Global Hemostatic Forceps Revenue by Region: 2021–2026
3.3.2 Global Hemostatic Forceps Revenue by Region: 2027–2032
3.4 North America Hemostatic Forceps Market Facts & Figures by Country
3.4.1 North America Hemostatic Forceps Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Hemostatic Forceps Sales by Country (2021–2032)
3.4.3 North America Hemostatic Forceps Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostatic Forceps Market Facts & Figures by Country
3.5.1 Europe Hemostatic Forceps Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Hemostatic Forceps Sales by Country (2021–2032)
3.5.3 Europe Hemostatic Forceps Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatic Forceps Market Facts & Figures by Region
3.6.1 Asia Pacific Hemostatic Forceps Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Hemostatic Forceps Sales by Region (2021–2032)
3.6.3 Asia Pacific Hemostatic Forceps Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostatic Forceps Market Facts & Figures by Country
3.7.1 Latin America Hemostatic Forceps Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Hemostatic Forceps Sales by Country (2021–2032)
3.7.3 Latin America Hemostatic Forceps Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatic Forceps Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatic Forceps Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Hemostatic Forceps Sales by Country (2021–2032)
3.8.3 Middle East and Africa Hemostatic Forceps Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostatic Forceps Sales by Type (2021–2032)
4.1.1 Global Hemostatic Forceps Sales by Type (2021–2026)
4.1.2 Global Hemostatic Forceps Sales by Type (2027–2032)
4.1.3 Global Hemostatic Forceps Sales Market Share by Type (2021–2032)
4.2 Global Hemostatic Forceps Revenue by Type (2021–2032)
4.2.1 Global Hemostatic Forceps Revenue by Type (2021–2026)
4.2.2 Global Hemostatic Forceps Revenue by Type (2027–2032)
4.2.3 Global Hemostatic Forceps Revenue Market Share by Type (2021–2032)
4.3 Global Hemostatic Forceps Price by Type (2021–2032)
5 Segment by Application
5.1 Global Hemostatic Forceps Sales by Application (2021–2032)
5.1.1 Global Hemostatic Forceps Sales by Application (2021–2026)
5.1.2 Global Hemostatic Forceps Sales by Application (2027–2032)
5.1.3 Global Hemostatic Forceps Sales Market Share by Application (2021–2032)
5.2 Global Hemostatic Forceps Revenue by Application (2021–2032)
5.2.1 Global Hemostatic Forceps Revenue by Application (2021–2026)
5.2.2 Global Hemostatic Forceps Revenue by Application (2027–2032)
5.2.3 Global Hemostatic Forceps Revenue Market Share by Application (2021–2032)
5.3 Global Hemostatic Forceps Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medline
6.1.1 Medline Company Information
6.1.2 Medline Description and Business Overview
6.1.3 Medline Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medline Hemostatic Forceps Product Portfolio
6.1.5 Medline Recent Developments/Updates
6.2 B. Braun
6.2.1 B. Braun Company Information
6.2.2 B. Braun Description and Business Overview
6.2.3 B. Braun Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 B. Braun Hemostatic Forceps Product Portfolio
6.2.5 B. Braun Recent Developments/Updates
6.3 CareFusion
6.3.1 CareFusion Company Information
6.3.2 CareFusion Description and Business Overview
6.3.3 CareFusion Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CareFusion Hemostatic Forceps Product Portfolio
6.3.5 CareFusion Recent Developments/Updates
6.4 Asa Dental
6.4.1 Asa Dental Company Information
6.4.2 Asa Dental Description and Business Overview
6.4.3 Asa Dental Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Asa Dental Hemostatic Forceps Product Portfolio
6.4.5 Asa Dental Recent Developments/Updates
6.5 Sklar
6.5.1 Sklar Company Information
6.5.2 Sklar Description and Business Overview
6.5.3 Sklar Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sklar Hemostatic Forceps Product Portfolio
6.5.5 Sklar Recent Developments/Updates
6.6 Scanlan International
6.6.1 Scanlan International Company Information
6.6.2 Scanlan International Description and Business Overview
6.6.3 Scanlan International Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Scanlan International Hemostatic Forceps Product Portfolio
6.6.5 Scanlan International Recent Developments/Updates
6.7 Shanghai Medical Instruments
6.7.1 Shanghai Medical Instruments Company Information
6.7.2 Shanghai Medical Instruments Description and Business Overview
6.7.3 Shanghai Medical Instruments Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Shanghai Medical Instruments Hemostatic Forceps Product Portfolio
6.7.5 Shanghai Medical Instruments Recent Developments/Updates
6.8 Lawton
6.8.1 Lawton Company Information
6.8.2 Lawton Description and Business Overview
6.8.3 Lawton Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Lawton Hemostatic Forceps Product Portfolio
6.8.5 Lawton Recent Developments/Updates
6.9 Hu-Friedy
6.9.1 Hu-Friedy Company Information
6.9.2 Hu-Friedy Description and Business Overview
6.9.3 Hu-Friedy Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hu-Friedy Hemostatic Forceps Product Portfolio
6.9.5 Hu-Friedy Recent Developments/Updates
6.10 Xinhua Surgical
6.10.1 Xinhua Surgical Company Information
6.10.2 Xinhua Surgical Description and Business Overview
6.10.3 Xinhua Surgical Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Xinhua Surgical Hemostatic Forceps Product Portfolio
6.10.5 Xinhua Surgical Recent Developments/Updates
6.11 Towne Brothers
6.11.1 Towne Brothers Company Information
6.11.2 Towne Brothers Description and Business Overview
6.11.3 Towne Brothers Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Towne Brothers Hemostatic Forceps Product Portfolio
6.11.5 Towne Brothers Recent Developments/Updates
6.12 Teleflex Medical
6.12.1 Teleflex Medical Company Information
6.12.2 Teleflex Medical Description and Business Overview
6.12.3 Teleflex Medical Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Teleflex Medical Hemostatic Forceps Product Portfolio
6.12.5 Teleflex Medical Recent Developments/Updates
6.13 Delacroix Chevalier
6.13.1 Delacroix Chevalier Company Information
6.13.2 Delacroix Chevalier Description and Business Overview
6.13.3 Delacroix Chevalier Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Delacroix Chevalier Hemostatic Forceps Product Portfolio
6.13.5 Delacroix Chevalier Recent Developments/Updates
6.14 YDM
6.14.1 YDM Company Information
6.14.2 YDM Description and Business Overview
6.14.3 YDM Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 YDM Hemostatic Forceps Product Portfolio
6.14.5 YDM Recent Developments/Updates
6.15 M A Corporation
6.15.1 M A Corporation Company Information
6.15.2 M A Corporation Description and Business Overview
6.15.3 M A Corporation Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 M A Corporation Hemostatic Forceps Product Portfolio
6.15.5 M A Corporation Recent Developments/Updates
6.16 MedGyn Products
6.16.1 MedGyn Products Company Information
6.16.2 MedGyn Products Description and Business Overview
6.16.3 MedGyn Products Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 MedGyn Products Hemostatic Forceps Product Portfolio
6.16.5 MedGyn Products Recent Developments/Updates
6.17 Inami
6.17.1 Inami Company Information
6.17.2 Inami Description and Business Overview
6.17.3 Inami Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Inami Hemostatic Forceps Product Portfolio
6.17.5 Inami Recent Developments/Updates
6.18 Ted Pella
6.18.1 Ted Pella Company Information
6.18.2 Ted Pella Description and Business Overview
6.18.3 Ted Pella Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Ted Pella Hemostatic Forceps Product Portfolio
6.18.5 Ted Pella Recent Developments/Updates
6.19 Medicon eG
6.19.1 Medicon eG Company Information
6.19.2 Medicon eG Description and Business Overview
6.19.3 Medicon eG Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Medicon eG Hemostatic Forceps Product Portfolio
6.19.5 Medicon eG Recent Developments/Updates
6.20 J & J Instruments
6.20.1 J & J Instruments Company Information
6.20.2 J & J Instruments Description and Business Overview
6.20.3 J & J Instruments Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 J & J Instruments Hemostatic Forceps Product Portfolio
6.20.5 J & J Instruments Recent Developments/Updates
6.21 American Diagnostic
6.21.1 American Diagnostic Company Information
6.21.2 American Diagnostic Description and Business Overview
6.21.3 American Diagnostic Hemostatic Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 American Diagnostic Hemostatic Forceps Product Portfolio
6.21.5 American Diagnostic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatic Forceps Industry Chain Analysis
7.2 Hemostatic Forceps Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatic Forceps Production Mode & Process Analysis
7.4 Hemostatic Forceps Sales and Marketing
7.4.1 Hemostatic Forceps Sales Channels
7.4.2 Hemostatic Forceps Distributors
7.5 Hemostatic Forceps Customer Analysis
8 Hemostatic Forceps Market Dynamics
8.1 Hemostatic Forceps Industry Trends
8.2 Hemostatic Forceps Market Drivers
8.3 Hemostatic Forceps Market Challenges
8.4 Hemostatic Forceps Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Hemostatic Forceps market size was US$ 67.75 million in 2025 and is forecast to reach a readjusted size of US$ 90.6 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 115
USD 4250.00
(Single User License)
The global market for Hemostatic Forceps was estimated to be worth US$ 67.75 million in 2025 and is projected to reach US$ 90.6 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 163
USD 3950.00
(Single User License)
The global Hemostatic Forceps market is projected to grow from US$ 65.2 million in 2024 to US$ 87.2 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 200
USD 4900.00
(Single User License)
In 2024, the global market size of Hemostatic Forceps was estimated to be worth US$ 65.2 million and is forecast to reach approximately US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 181
USD 5900.00
(Single User License)
The global Hemostatic Forceps market size was US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 111
USD 4250.00
(Single User License)
The global market for Hemostatic Forceps was estimated to be worth US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 159
USD 3950.00
(Single User License)
The global market for Hemostatic Forceps was valued at US$ 65.2 million in the year 2024 and is projected to reach a revised size of US$ 87.2 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-01-16
Pages: 117
USD 2900.00
(Single User License)
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-17
Pages: 207
USD 5600.00
(Single User License)
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-16
Pages: 186
USD 5900.00
(Single User License)
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-07
Pages: 129
USD 4900.00
(Single User License)
The global Hemostatic Forceps market size was US$ 67.75 million in 2025 and is forecast to reach a readjusted size of US$ 90.6 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 115
The global market for Hemostatic Forceps was estimated to be worth US$ 67.75 million in 2025 and is projected to reach US$ 90.6 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 163
The global Hemostatic Forceps market is projected to grow from US$ 65.2 million in 2024 to US$ 87.2 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 200
In 2024, the global market size of Hemostatic Forceps was estimated to be worth US$ 65.2 million and is forecast to reach approximately US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 181
The global Hemostatic Forceps market size was US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 111
The global market for Hemostatic Forceps was estimated to be worth US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 159
The global market for Hemostatic Forceps was valued at US$ 65.2 million in the year 2024 and is projected to reach a revised size of US$ 87.2 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-01-16
Pages: 117
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-17
Pages: 207
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-16
Pages: 186
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-07
Pages: 129
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now